Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate cancer screening.

Shandra S Wilson1

  • 1Division of Urology, Anschutz Cancer Center, Denver, CO, USA. shandra.wilson@uchsc.edu

Comprehensive Therapy
|May 20, 2005
PubMed
Summary
This summary is machine-generated.

Prostate cancer screening using prostate-specific antigen (PSA) improves early detection. This leads to better treatment outcomes, including reduced mortality and metastasis rates for this common cancer in men.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial.

JAMA·2018
Same author

The effect of digital rectal exam on the 4Kscore for aggressive prostate cancer.

The Prostate·2018
Same author

Fewer Recurrences with Immediate versus Delayed Intravesical Mitomycin C: A Prospective Randomized European Trial.

European urology·2017
Same author

Seventy-Year-Old Man With Large Bladder Mass: Diagnostic and Clinical Challenges of an Uncommon Neoplasm.

Oncology (Williston Park, N.Y.)·2017
Same author

Lymphoepithelioma-Like Carcinoma of the Urinary Bladder.

Oncology (Williston Park, N.Y.)·2015
Same author

Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial.

European urology·2014
Same journal

Heparin-induced thrombocytopenia and thrombosis.

Comprehensive therapy·2011
Same journal

Antiplatelet therapy in cardiovascular disease.

Comprehensive therapy·2011
Same journal

Genetics of cardiovascular disease.

Comprehensive therapy·2011
Same journal

Septic renal vein thrombosis complicated by septic pulmonary embolism.

Comprehensive therapy·2011
Same journal

Gout and hyperuricemia.

Comprehensive therapy·2011
Same journal

Problems with computerized health records.

Comprehensive therapy·2011
See all related articles

Area of Science:

  • Urology
  • Oncology
  • Public Health

Background:

  • Prostate cancer is the most common noncutaneous cancer affecting men in Western countries.
  • Its significant prevalence necessitates effective screening strategies to mitigate morbidity and mortality.

Purpose of the Study:

  • To review the sensitivity and specificity of prostate-specific antigen (PSA) testing.
  • To discuss methods for enhancing PSA test validity.
  • To highlight the significance of detecting clinically relevant prostate cancers through screening.

Main Methods:

  • Review of current literature on prostate-specific antigen (PSA) testing.
  • Analysis of techniques aimed at improving PSA test accuracy.
  • Examination of screening outcomes, including stage migration and mortality rates.

Related Experiment Videos

Main Results:

  • Screening for prostate cancer demonstrates improved test validity through enhanced techniques.
  • Early detection facilitates a downward stage migration for diagnosed cancers.
  • Screened and treated patients exhibit decreased disease-specific mortality and lower rates of metastasis.

Conclusions:

  • Prostate-specific antigen (PSA) screening plays a crucial role in managing prostate cancer.
  • Effective screening strategies contribute to earlier diagnosis and improved patient survival.
  • Ongoing advancements in testing aim to maximize the benefits of prostate cancer screening.